Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-07-029217
Filing Date
2007-05-03
Accepted
2007-05-03 11:17:19
Documents
1
Period of Report
2007-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd156610.html 4  
1 FORM 4 rrd156610.xml 4 17835
  Complete submission text file 0001181431-07-029217.txt   19552
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

EIN.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address DEUTSCHE BANK ASSET MANAGEMENT 6TH FLOOR 280 PARK AVENUE NEW YORK NY 10017
Business Address 2124541219
SHIEBLER WILLIAM N (Reporting) CIK: 0001221432 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 07813672